Automated optimization of TMS coil placement for personalized functional network engagement.
electric field modeling
functional brain networks
precision functional mapping
transcranial magnetic stimulation
Journal
Neuron
ISSN: 1097-4199
Titre abrégé: Neuron
Pays: United States
ID NLM: 8809320
Informations de publication
Date de publication:
19 10 2022
19 10 2022
Historique:
received:
31
03
2022
revised:
20
05
2022
accepted:
05
08
2022
pubmed:
17
9
2022
medline:
25
10
2022
entrez:
16
9
2022
Statut:
ppublish
Résumé
Transcranial magnetic stimulation (TMS) is used to treat multiple psychiatric and neurological conditions by manipulating activity in particular brain networks and circuits, but individual responses are highly variable. In clinical settings, TMS coil placement is typically based on either group average functional maps or scalp heuristics. Here, we found that this approach can inadvertently target different functional networks in depressed patients due to variability in their functional brain organization. More precise TMS targeting should be feasible by accounting for each patient's unique functional neuroanatomy. To this end, we developed a targeting approach, termed targeted functional network stimulation (TANS). The TANS approach improved stimulation specificity in silico in 8 highly sampled patients with depression and 6 healthy individuals and in vivo when targeting somatomotor functional networks representing the upper and lower limbs. Code for implementing TANS and an example dataset are provided as a resource.
Identifiants
pubmed: 36113473
pii: S0896-6273(22)00744-9
doi: 10.1016/j.neuron.2022.08.012
pii:
doi:
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Research Support, N.I.H., Extramural
Langues
eng
Sous-ensembles de citation
IM
Pagination
3263-3277.e4Subventions
Organisme : NIMH NIH HHS
ID : F32 MH120989
Pays : United States
Informations de copyright
Copyright © 2022 The Author(s). Published by Elsevier Inc. All rights reserved.
Déclaration de conflit d'intérêts
Declaration of interests C.L. is listed as an inventor for Cornell University patent applications on neuroimaging biomarkers for depression that are pending or in preparation. C.L. has served as a scientific advisor or consultant to Compass Pathways PLC, Delix Therapeutics, Magnus Medical, and Brainify.AI.